The molecular basis of HIV entry
- PMID: 22583677
- PMCID: PMC3417324
- DOI: 10.1111/j.1462-5822.2012.01812.x
The molecular basis of HIV entry
Abstract
Infection by HIV starts when the virus attaches to a susceptible cell. For viral replication to continue, the viral envelope must fuse with a cellular membrane, thereby delivering the viral core to the cytoplasm, where the RNA genome is reverse-transcribed. The key players in this entry by fusion are the envelope glycoprotein, on the viral side, and CD4 and a co-receptor, CCR5 or CXCR4, on the cellular side. Here, the interplay of these molecules is reviewed from cell-biological, structural, mechanistic, and modelling-based perspectives. Hypotheses are evaluated regarding the cellular compartment for entry, the transfer of virus through direct cell-to-cell contact, the sequence of molecular events, and the number of molecules involved on each side of the virus-cell divide. An emerging theme is the heterogeneity among the entry mediators on both sides, a diversity that affects the efficacy of entry inhibitors, be they small-molecule ligands, peptides or neutralizing antibodies. These insights inform rational strategies for therapy as well as vaccination.
© 2012 Blackwell Publishing Ltd.
Figures






Similar articles
-
A Membrane-Anchored Short-Peptide Fusion Inhibitor Fully Protects Target Cells from Infections of Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.J Virol. 2019 Oct 29;93(22):e01177-19. doi: 10.1128/JVI.01177-19. Print 2019 Nov 15. J Virol. 2019. PMID: 31462566 Free PMC article.
-
HIV-1 Entry and Membrane Fusion Inhibitors.Viruses. 2021 Apr 23;13(5):735. doi: 10.3390/v13050735. Viruses. 2021. PMID: 33922579 Free PMC article. Review.
-
[Viral entry as therapeutic target. Current situation of entry inhibitors].Enferm Infecc Microbiol Clin. 2008 Oct;26 Suppl 11:5-11. doi: 10.1016/s0213-005x(08)76557-1. Enferm Infecc Microbiol Clin. 2008. PMID: 19133215 Review. Spanish.
-
Molecular Mechanism of HIV-1 Entry.Trends Microbiol. 2019 Oct;27(10):878-891. doi: 10.1016/j.tim.2019.06.002. Epub 2019 Jun 28. Trends Microbiol. 2019. PMID: 31262533 Free PMC article. Review.
-
[Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].Acta Med Port. 2008 Sep-Oct;21(5):497-504. Epub 2009 Jan 16. Acta Med Port. 2008. PMID: 19187693 Review. Portuguese.
Cited by
-
Burkholderia oklahomensis agglutinin is a canonical two-domain OAA-family lectin: structures, carbohydrate binding and anti-HIV activity.FEBS J. 2013 May;280(9):2056-67. doi: 10.1111/febs.12229. Epub 2013 Apr 2. FEBS J. 2013. PMID: 23480609 Free PMC article.
-
The V1 region of gp120 is preferentially selected during SIV/HIV transmission and is indispensable for envelope function and virus infection.Virol Sin. 2016 Jun;31(3):207-18. doi: 10.1007/s12250-016-3725-5. Epub 2016 Apr 19. Virol Sin. 2016. PMID: 27117672 Free PMC article.
-
CXCR4 Is a Potential Target for Anti-HIV Gene Therapy.Int J Mol Sci. 2024 Jan 18;25(2):1187. doi: 10.3390/ijms25021187. Int J Mol Sci. 2024. PMID: 38256260 Free PMC article. Review.
-
Variants in human papillomavirus receptor and associated genes are associated with type-specific HPV infection and lesion progression of the cervix.Oncotarget. 2016 Jun 28;7(26):40135-40147. doi: 10.18632/oncotarget.9510. Oncotarget. 2016. PMID: 27223085 Free PMC article.
-
HIV-1 Escape from a Peptidic Anchor Inhibitor through Stabilization of the Envelope Glycoprotein Spike.J Virol. 2016 Nov 14;90(23):10587-10599. doi: 10.1128/JVI.01616-16. Print 2016 Dec 1. J Virol. 2016. PMID: 27654295 Free PMC article.
References
-
- Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 1996;272:1955–1958. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials